These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12604694)

  • 1. Modulatory effect of bolinaquinone, a marine sesquiterpenoid, on acute and chronic inflammatory processes.
    Lucas R; Giannini C; D'auria MV; Payá M
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1172-80. PubMed ID: 12604694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cycloamphilectenes, a new type of potent marine diterpenes: inhibition of nitric oxide production in murine macrophages.
    Lucas R; Casapullo A; Ciasullo L; Gomez-Paloma L; Payá M
    Life Sci; 2003 Apr; 72(22):2543-52. PubMed ID: 12650863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation.
    Garcia-Pastor P; Randazzo A; Gomez-Paloma L; Alcaraz MJ; Paya M
    J Pharmacol Exp Ther; 1999 Apr; 289(1):166-72. PubMed ID: 10087000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An anti-inflammatory ditriazine inhibiting leukocyte functions and expression of inducible nitric oxide synthase and cyclo-oxygenase-2.
    Rioja I; Ubeda A; Terencio MC; Guillén I; Riguera R; Quintela JM; Peinador C; González LM; Alcaraz MJ
    Eur J Pharmacol; 2000 May; 397(1):207-17. PubMed ID: 10844115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel indazolo-triazolo-benzotriazepine exerts anti-inflammatory effects by inhibition of cyclooxygenase-2 activity and nitric oxide synthase-2 expression.
    Fernández P; Guillén MI; Ubeda A; López-Cremades P; Aller E; Lorenzo A; Molina P; Alcaraz MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jul; 368(1):26-32. PubMed ID: 12827217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysidotronic acid, a new sesquiterpenoid, inhibits cytokine production and the expression of nitric oxide synthase.
    Posadas I; Terencio MC; Giannini C; D'Auria MV; Payá M
    Eur J Pharmacol; 2001 Mar; 415(2-3):285-92. PubMed ID: 11275011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic administration of 3,4,5-trimethoxy-4'-fluorochalcone, a selective inhibitor of iNOS expression, attenuates the development of adjuvant-induced arthritis in rats.
    Rojas J; Payá M; Devesa I; Dominguez JN; Ferrándiz ML
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Sep; 368(3):225-33. PubMed ID: 12904830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-(2,3,4-trimethoxyphenyl)-3-(3-(2-chloroquinolinyl))-2-propen-1-one, a chalcone derivative with analgesic, anti-inflammatory and immunomodulatory properties.
    De León EJ; Alcaraz MJ; Dominguez JN; Charris J; Terencio MC
    Inflamm Res; 2003 Jun; 52(6):246-57. PubMed ID: 12835896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of Buthus martensi Karsch extracts on interleukin-1beta-induced expression of nitric oxide (NO) synthase and production of NO in human chondrocytes and LPS-induced NO and prostaglandin E2 production in mouse peritoneal macrophages.
    Kim KS; Cho HS; Lee SD; Kim KH; Cho JY; Chung KH; Lee YC; Moon SK; Kim CH
    Toxicol In Vitro; 2005 Sep; 19(6):757-69. PubMed ID: 15963682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variabilin: a dual inhibitor of human secretory and cytosolic phospholipase A2 with anti-inflammatory activity.
    Escrig V; Ubeda A; Ferrandiz ML; Darias J; Sanchez JM; Alcaraz MJ; Paya M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):123-31. PubMed ID: 9223548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the anti-inflammatory and analgesic activity of Me-UCH9, a dual cyclooxygenase-2/5-lipoxygenase inhibitor.
    Araico A; Terencio MC; Alcaraz MJ; Domínguez JN; León C; Ferrándiz ML
    Life Sci; 2007 May; 80(23):2108-2117. PubMed ID: 17490689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory effects of a traditional Korean herbal formulation, Silsosangami, consisting of seven medicinal herbs: effect on hemolysis, neutrophil function, and gene expressions of iNOS and COX-2.
    Park WH; Kim CH; Lee YC; Kim CH
    Vascul Pharmacol; 2004 Aug; 42(1):7-15. PubMed ID: 15664882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of haem oxygenase-1 expression by nitric oxide and leukotrienes in zymosan-activated macrophages.
    Vicente AM; Guillén MI; Alcaraz MJ
    Br J Pharmacol; 2001 Jul; 133(6):920-6. PubMed ID: 11454666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2.
    García Pastor P; De Rosa S; De Giulio A; Payá M; Alcaraz MJ
    Br J Pharmacol; 1999 Jan; 126(1):301-11. PubMed ID: 10051149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel anti-inflammatory chalcone derivatives inhibit the induction of nitric oxide synthase and cyclooxygenase-2 in mouse peritoneal macrophages.
    Herencia F; Ferrándiz ML; Ubeda A; Guillén I; Dominguez JN; Charris JE; Lobo GM; Alcaraz MJ
    FEBS Lett; 1999 Jun; 453(1-2):129-34. PubMed ID: 10403389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LAAE-14, a new in vitro inhibitor of intracellular calcium mobilization, modulates acute and chronic inflammation.
    Lucas R; Alves M; del Olmo E; San Feliciano A; Payá M
    Biochem Pharmacol; 2003 May; 65(9):1539-49. PubMed ID: 12732367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory effect of the oligomeric stilbene alpha-Viniferin and its mode of the action through inhibition of cyclooxygenase-2 and inducible nitric oxide synthase.
    Chung EY; Kim BH; Lee MK; Yun YP; Lee SH; Min KR; Kim Y
    Planta Med; 2003 Aug; 69(8):710-4. PubMed ID: 14531020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of 5-lipoxygenase activity by the natural anti-inflammatory compound aethiopinone.
    Benrezzouk R; Terencio MC; Ferrandiz ML; Hernandez-Perez M; Rabanal R; Alcaraz MJ
    Inflamm Res; 2001 Feb; 50(2):96-101. PubMed ID: 11289660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
    Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
    J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host response to infection: the role of CpG DNA in induction of cyclooxygenase 2 and nitric oxide synthase 2 in murine macrophages.
    Ghosh DK; Misukonis MA; Reich C; Pisetsky DS; Weinberg JB
    Infect Immun; 2001 Dec; 69(12):7703-10. PubMed ID: 11705951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.